Celloid Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $6.19M

  • Investors
  • 7

Celloid General Information

Description

Developer of a cell culture platform and automation system designed to provide an optimal environment for three-dimensional cell culture. The company offers quality-controlled long-term organoid culture with homogeneity, reproducibility, and automated culture capabilities, enabling healthcare organizations to support drug development, diagnostics, and regenerative medicine with consistent cell cultivation processes.

Contact Information

Website
www.celloid.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • CHANGeUp Ground 626
  • 87, Cheongam-ro, Nam-gu
  • Pohang, Gyeongsangbuk
  • South Korea
+82
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • CHANGeUp Ground 626
  • 87, Cheongam-ro, Nam-gu
  • Pohang, Gyeongsangbuk
  • South Korea
+82

Celloid Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celloid Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 11-Mar-2026 $6.19M Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
5. Accelerator/Incubator 01-Jun-2025 Completed Generating Revenue
4. Accelerator/Incubator 01-Apr-2024 Completed Generating Revenue
3. Early Stage VC (Series A) 30-Jan-2024 Completed Generating Revenue
2. Seed Round 01-Jun-2022 Completed Generating Revenue
1. Accelerator/Incubator 01-Jun-2022 Completed Generating Revenue
To view Celloid’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Celloid Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

Celloid Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025226067-A1 Automated modular cell culture apparatus having perfusion-based culture medium transfer function Pending 24-Apr-2024
EP-4782021-A1 Porous membrane and method for manufacturing same Pending 20-Oct-2023
US-20260250885-A1 Porous membrane and method for manufacturing same Pending 20-Oct-2023
WO-2025084878-A1 Porous membrane and method for manufacturing same Inactive 20-Oct-2023
EP-4674945-A1 Cartridge for adherent cell culture, and cell culture device including same Pending 15-Mar-2023 C12M23/42
To view Celloid’s complete patent history, request access »

Celloid Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celloid Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
DSC Investment Venture Capital Minority
Schmidt (South Korea) Venture Capital Minority
SUPERSTART Accelerator/Incubator
Seoul Biohub Accelerator/Incubator
FuturePlay Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Celloid FAQs

  • When was Celloid founded?

    Celloid was founded in 2021.

  • Where is Celloid headquartered?

    Celloid is headquartered in Pohang, South Korea.

  • What is the size of Celloid?

    Celloid has 15 total employees.

  • What industry is Celloid in?

    Celloid’s primary industry is Discovery Tools (Healthcare).

  • Is Celloid a private or public company?

    Celloid is a Private company.

  • What is the current valuation of Celloid?

    The current valuation of Celloid is .

  • What is Celloid’s current revenue?

    The current revenue for Celloid is .

  • How much funding has Celloid raised over time?

    Celloid has raised $8.85M.

  • Who are Celloid’s investors?

    DSC Investment, Schmidt (South Korea), SUPERSTART, Seoul Biohub, and FuturePlay are 5 of 7 investors who have invested in Celloid.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process